Donaldson Acquires Univercells Technologies For €136M
Portfolio Pulse from Akanksha Bakshi
Donaldson Company Inc (NYSE:DCI) has announced the acquisition of Univercells Technologies for €136 million. Univercells is a global producer of biomanufacturing solutions for cell and gene therapy research, development, and commercial manufacturing. The acquisition is expected to expand Donaldson's life sciences product portfolio.
June 30, 2023 | 11:20 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Donaldson's acquisition of Univercells Technologies for €136 million could potentially expand its life sciences product portfolio and strengthen its position in the market.
The acquisition of Univercells Technologies, a global producer of biomanufacturing solutions, could potentially expand Donaldson's life sciences product portfolio and strengthen its position in the market. This could lead to increased revenues and profitability in the future, which could positively impact the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100